$0
+$0(0,00 %)
Keine Daten
*Data last updated: 2026-04-28 20:20 (UTC+8)
As of 2026-04-28 20:20, Iovance Biotherapeutics Inc (IOVA) is priced at $0, with a total market cap of $1,13B, a P/E ratio of -2,49, and a dividend yield of 0,00 %. Today, the stock price fluctuated between $0 and $0. The current price is 0,00 % above the day's low and 0,00 % below the day's high, with a trading volume of 10,18M. Over the past 52 weeks, IOVA has traded between $0 to $0, and the current price is 0,00 % away from the 52-week high.
IOVA Key Stats
Yesterday's Close$3
Market Cap$1,13B
Volumen10,18M
P/E Ratio-2,49
Dividend Yield (TTM)0,00 %
Diluted EPS (TTM)0,97
Net Income (FY)-$390,97M
Revenue (FY)$263,50M
Earnings Date2026-05-07
EPS Estimate0,19
Revenue Estimate$77,83M
Shares Outstanding330,72M
Beta (1Y)0.764
About IOVA
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.
SectorHealthcare
IndustryBiotechnology
CEOFrederick G. Vogt
HeadquartersSan Carlos,CA,US
Official Websitehttps://www.iovance.com
Employees (FY)975,00
Average Revenue (1Y)$270,25K
Net Income per Employee-$401,00K
Iovance Biotherapeutics Inc (IOVA) FAQ
What's the stock price of Iovance Biotherapeutics Inc (IOVA) today?
x
Iovance Biotherapeutics Inc (IOVA) is currently trading at $0, with a 24h change of 0,00 %. The 52-week trading range is $0–$0.
What are the 52-week high and low prices for Iovance Biotherapeutics Inc (IOVA)?
x
What is the price-to-earnings (P/E) ratio of Iovance Biotherapeutics Inc (IOVA)? What does it indicate?
x
What is the market cap of Iovance Biotherapeutics Inc (IOVA)?
x
What is the most recent quarterly earnings per share (EPS) for Iovance Biotherapeutics Inc (IOVA)?
x
Should you buy or sell Iovance Biotherapeutics Inc (IOVA) now?
x
What factors can affect the stock price of Iovance Biotherapeutics Inc (IOVA)?
x
How to buy Iovance Biotherapeutics Inc (IOVA) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.